Sporadic fetal brain disruption sequence

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1665Q02
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Fetal brain disruption sequence (FBDS) is an extremely rare condition in which a previously normally developing fetal brain suffers a destructive insult during gestation, leading to severe brain damage and a characteristic pattern of abnormalities at birth. The condition is classified as sporadic, meaning it occurs without a clear familial or genetic inheritance pattern. The underlying cause is thought to involve a vascular disruption, infection (such as congenital cytomegalovirus or Zika virus), or other insult that damages the developing brain tissue, leading to collapse of the fetal skull. The hallmark features of fetal brain disruption sequence include severe microcephaly (abnormally small head, ICD-10: Q02) with overlapping cranial sutures, prominent occipital bone, and scalp rugae (redundant, wrinkled scalp skin). The brain itself shows extensive destruction, often with large areas of encephalomalacia or porencephaly, and the cerebral hemispheres may be largely replaced by fluid-filled cavities. Neurological impairment is profound, and affected infants typically present with severe intellectual disability, seizures, spasticity, and failure to thrive. Other findings may include cortical visual impairment and feeding difficulties. There is no curative treatment for fetal brain disruption sequence. Management is supportive and symptomatic, focusing on seizure control with anticonvulsant medications, nutritional support (which may require gastrostomy tube feeding), physical therapy, and management of associated complications. The prognosis is generally very poor, with many affected infants experiencing significant morbidity and shortened life expectancy. Genetic counseling is recommended for families, though the recurrence risk is generally considered low given the sporadic and disruptive (non-genetic) nature of the condition in most cases.

Clinical phenotype terms— hover any for plain English:

Abnormality of the adrenal glandsHP:0000834Aplasia/Hypoplasia of the thymusHP:0010515
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Sporadic fetal brain disruption sequence.

View clinical trials →

No actively recruiting trials found for Sporadic fetal brain disruption sequence at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Sporadic fetal brain disruption sequence community →

No specialists are currently listed for Sporadic fetal brain disruption sequence.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Sporadic fetal brain disruption sequence.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Sporadic fetal brain disruption sequenceForum →

No community posts yet. Be the first to share your experience with Sporadic fetal brain disruption sequence.

Start the conversation →

Latest news about Sporadic fetal brain disruption sequence

No recent news articles for Sporadic fetal brain disruption sequence.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Sporadic fetal brain disruption sequence

What is Sporadic fetal brain disruption sequence?

Fetal brain disruption sequence (FBDS) is an extremely rare condition in which a previously normally developing fetal brain suffers a destructive insult during gestation, leading to severe brain damage and a characteristic pattern of abnormalities at birth. The condition is classified as sporadic, meaning it occurs without a clear familial or genetic inheritance pattern. The underlying cause is thought to involve a vascular disruption, infection (such as congenital cytomegalovirus or Zika virus), or other insult that damages the developing brain tissue, leading to collapse of the fetal skull.

How is Sporadic fetal brain disruption sequence inherited?

Sporadic fetal brain disruption sequence follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Sporadic fetal brain disruption sequence typically begin?

Typical onset of Sporadic fetal brain disruption sequence is neonatal. Age of onset can vary across affected individuals.